MediPharm Labs Corp. (LABS.TO)

CAD 0.06

(-7.69%)

Operating Expenses Summary of MediPharm Labs Corp.

MediPharm Labs Corp.'s latest annual operating expenses in 2023 was 23.08 Million CAD , down -14.12% from previous year.
MediPharm Labs Corp.'s latest quarterly operating expenses in 2024 Q2 was 5.95 Million CAD , down -8.94% from previous quarter.
MediPharm Labs Corp. reported a annual operating expenses of 26.87 Million CAD in annual operating expenses 2022, down -3.19% from previous year.
MediPharm Labs Corp. reported a annual operating expenses of 27.76 Million CAD in annual operating expenses 2021, up 2.64% from previous year.
MediPharm Labs Corp. reported a quarterly operating expenses of 6.54 Million CAD for 2024 Q1, up 22.85% from previous quarter.
MediPharm Labs Corp. reported a quarterly operating expenses of 23.08 Million CAD for 2023 FY, down -14.12% from previous quarter.

Annual Operating Expenses Chart of MediPharm Labs Corp. (2023 - 2016)

Historical Annual Operating Expenses of MediPharm Labs Corp. (2023 - 2016)

Year	Operating Expenses	Operating Expenses Growth
2023	23.08 Million CAD	-14.12%
2022	26.87 Million CAD	-3.19%
2021	27.76 Million CAD	2.64%
2020	27.05 Million CAD	-24.81%
2019	35.97 Million CAD	199.95%
2018	11.99 Million CAD	1113.97%
2017	988 Thousand CAD	637.67%
2016	133.93 Thousand CAD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q2	5.95 Million CAD	-8.94%
2024 Q1	6.54 Million CAD	22.85%
2023 FY	23.08 Million CAD	-14.12%
2023 Q4	5.32 Million CAD	-21.35%
2023 Q3	6.77 Million CAD	-20.18%
2023 Q2	8.48 Million CAD	128.06%
2023 Q1	3.72 Million CAD	-15.13%
2022 Q1	7.1 Million CAD	-37.08%
2022 FY	26.87 Million CAD	-3.19%
2022 Q4	4.38 Million CAD	-36.07%
2022 Q3	6.85 Million CAD	-19.69%
2022 Q2	8.53 Million CAD	20.22%
2021 FY	27.76 Million CAD	2.64%
2021 Q4	11.28 Million CAD	101.66%
2021 Q3	5.59 Million CAD	53.44%
2021 Q2	3.64 Million CAD	-49.59%
2021 Q1	7.23 Million CAD	131.97%
2020 Q3	6.15 Million CAD	-8.33%
2020 Q2	6.71 Million CAD	-39.21%
2020 Q1	11.05 Million CAD	-11.5%
2020 FY	27.05 Million CAD	-24.81%
2020 Q4	3.11 Million CAD	-49.36%
2019 FY	35.97 Million CAD	199.95%
2019 Q3	9.38 Million CAD	32.54%
2019 Q2	7.08 Million CAD	1.0%
2019 Q1	7.01 Million CAD	-0.55%
2019 Q4	12.48 Million CAD	33.02%
2018 Q4	7.05 Million CAD	6630.41%
2018 Q2	11.94 Thousand CAD	-94.26%
2018 Q1	208.27 Thousand CAD	849.45%
2018 FY	11.99 Million CAD	1113.97%
2018 Q3	104.79 Thousand CAD	777.0%
2017 FY	988 Thousand CAD	637.67%
2017 Q3	39.78 Thousand CAD	29.34%
2017 Q2	30.76 Thousand CAD	-71.12%
2017 Q1	106.52 Thousand CAD	0.0%
2017 Q4	21.93 Thousand CAD	-44.86%
2016 FY	133.93 Thousand CAD	0.0%

Peer Operating Expenses Comparison of MediPharm Labs Corp.

Name	Operating Expenses	Operating Expenses Difference
Aurora Cannabis Inc.	158.53 Million CAD	85.44%
Avicanna Inc.	14.59 Million CAD	-58.193%
Avant Brands Inc.	5.65 Million CAD	-307.899%
Cardiol Therapeutics Inc.	29.53 Million CAD	21.851%
Crescita Therapeutics Inc.	12.32 Million CAD	-87.362%
Knight Therapeutics Inc.	155.54 Million CAD	85.16%
OrganiGram Holdings Inc.	277.81 Million CAD	91.691%
Canopy Growth Corporation	308.61 Million CAD	92.52%
Willow Biosciences Inc.	7.55 Million CAD	-205.573%
Auxly Cannabis Group Inc.	40.28 Million CAD	42.696%